检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Eribulin versus S1 as first- or second-line chemotherapy to assess Health-related Quality of Life and overall survival in HER2-negative metastatic breast cancer (RESQ study): a non-inferiority, randomized controlled trial

Yuichiro Kikawa, Kosuke Kashiwabara,Naruto Taira, Tsuguo Iwatani,Kojiro Shimozuma,Shoichiro Ohtani,Tetsuhiro Yoshinami,Junichiro Watanabe,Masahiro Kashiwaba,Ken-ichi Watanabe, Masahiro Kitada, Koichi Sakaguchi,Yuko Tanabe,Tomohiko Aihara,Hirofumi Mukai,Masato Takahashi

CANCER RESEARCH（2023）

引用 0|浏览14
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要